LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma

Abstract

BackgroundAccumulating evidence indicates that long non-coding RNAs (lncRNAs) play a crucial role in tumorigenesis. Here, we report a novel lncRNA, RP11-436H11.5, that regulates renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-335-5p.MethodsExpression of lncRNA RP11-436H11.5 was determined by a qRT-PCR assay in RCC tissues. RCC cell proliferation and invasion were measured by a cell proliferation assay and a transwell invasion assay. Expression of BCL-W was detected by a western blot assay. Interactions between lncRNA RP11-436H11.5 and miR-335-5p were measured by a luciferase reporter assay and a RNA-pull down assay. In vivo experiments were used to detect tumor formation.ResultsIn this study, the qRT-PCR results illustrated that lncRNA RP11-436H11.5 was more highly expressed in RCC tissues than in adjacent normal renal tissues. The results of survival analysis indicated that patients in the high lncRNA RP11-436H11.5 group presented significantly worse outcomes compared with those in the low lncRNA RP11-436H11.5 group. Downregulation of lncRNA RP11-436H11.5 suppressed RCC cell proliferation and invasion in vitro and in vivo. Luciferase reporter assay results demonstrated that lncRNA RP11-436H11.5 enhanced BCL-W expression by regulating miR-335-5p expression. LncRNA RP11-436H11.5 could function as a miR-335-5p decoy to derepress expression of BCL-W.ConclusionsLncRNA RP11-436H11.5 could function as a competing endogenous RNA to promote RCC cell proliferation and invasion, which might serve as a therapeutic application to suppress RCC progression.Electronic supplementary materialThe online version of this article (10.1186/s12943-017-0735-3) contains supplementary material, which is available to authorized users.

H3K27ac‐activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR‐450b‐5p/miR‐515‐5p/YAP1 axis

“…It is reported that lncRNAs regulated tumour progression via diverse mechanisms. For example, lncRNA MALAT1 modulates gastric cancer cell autophagy via sequestrating miR‐23b‐3p 30. LncRNA HOXB‐AS3A encodes peptide to restrain cell growth in colon cancer growth 31.…”

Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis

“…It is wellknown that lncRNAs usually exert ceRNA function in human cancers via sponging miRNAs. [30][31][32] Based on the bioinformatics analysis, ten candidate miRNAs were chosen for further analysis.…”

Long noncoding RNA MALAT1 regulates HDAC4‐mediated proliferation and apoptosis via decoying of miR‐140‐5p in osteosarcoma cells

“…Wild and mutant reporter plasmids of MALAT1/HDAC4 wt‐MALAT1‐luc/wt‐HDAC4‐luc and mut‐MALAT1‐luc/mut‐HDAC4‐luc which containing a wild or a mutant miR‐140‐5p binding sites were synthesized by GenePharma (GenePharma, Shanghai, China). The procedure was carried out as previously described . In brief, when HOS and 143B cells grew to 70% confluence, wt‐MALAT1‐luc/wt‐HDAC4‐luc, and mut‐MALAT1‐luc/mut‐HDAC4‐luc were cotransfected with miR‐140‐5p mimics or mimic control using a Lipofectamine 3000 (Invitrogen), individually.…”

“…The procedure was carried out as previously described. 31 In brief, when HOS and 143B cells grew to 70% confluence, wt-MALAT1-luc/ wt-HDAC4-luc, and mut-MALAT1-luc/mut-HDAC4-luc were cotransfected with miR-140-5p mimics or mimic control using a Lipofectamine 3000 (Invitrogen), individually. Forty-eight hours later, luminescence changes in each group were determined using a Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) according to the manufacturer's protocol.…”